85866-02-0

Basic information

• Product Name: 7-OCTENE-1,2-DIOL
• Synonyms: 7-OCTENE-1,2-DIOL;oct-7-ene-1,2-diol;7-OCTENE-1,2-DIOL, 97% (NO BULK SALES ALLOWED);7-Octene-1,2-diol, GC 97%;Einecs 288-704-6;)-1-Octene-7,8-diol;7,8-Dihydroxy-1-octene;7-Octene-1,2-diol 97%
• CAS NO: 85866-02-0
• Molecular Formula: C₈H₁₆O₂
• Molecular Weight: 144.21
• EINECS: 288-704-6
• Product Categories: Alcohols;Monomers;Polymer Science
• Mol File: 85866-02-0.mol

Chemical Properties

• Boiling Point: 256°Cat760mmHg
• Flash Point: 113 °C
• Appearance: /
• Density: 0.941 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.00238mmHg at 25°C
• Refractive Index: n20/D 1.4625(lit.)
• PKA: 14.44±0.20(Predicted)
• CAS DataBase Reference: 7-OCTENE-1,2-DIOL(CAS DataBase Reference)
• NIST Chemistry Reference: 7-OCTENE-1,2-DIOL(85866-02-0)
• EPA Substance Registry System: 7-OCTENE-1,2-DIOL(85866-02-0)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 85866-02-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
7-Octene-1,2-diol is used as a precursor for the synthesis of various pharmaceuticals. Its chemical structure allows for the creation of diverse medicinal compounds, contributing to the development of new drugs and therapies.
Used in Chemical Industry:
7-Octene-1,2-diol is used as a precursor for the production of solvents and fragrances. Its ability to form stable compounds with other chemicals makes it a valuable component in the formulation of various products.
Used in Plasticizer Production:
7-Octene-1,2-diol is used as a raw material in the manufacturing of plasticizers. These additives are incorporated into plastics to increase their flexibility and durability, enhancing their performance in various applications.
Used in Lubricant Formulation:
7-Octene-1,2-diol is used in the formulation of lubricants due to its ability to reduce friction and wear between moving parts. This contributes to the efficiency and longevity of machinery and equipment in various industries.
Used in Surfactant Production:
7-Octene-1,2-diol is used as a component in the production of surfactants, which are essential in the creation of detergents, cleaners, and other products that require the reduction of surface tension.
Used in Personal Care and Cosmetics Industry:
7-Octene-1,2-diol is used in the formulation of personal care products and cosmetics due to its antimicrobial properties. This helps to preserve the products and maintain their efficacy over time.

InChI:InChI=1/C8H16O2/c1-2-3-4-5-6-8(10)7-9/h2,8-10H,1,3-7H2

Upstream product

• 52485-73-1 1,2-epoxy-7-octene 
• 3710-30-3 1,7-Octadiene 

Downstream Products

• 1274891-85-8 2-(5'-hexenyl)glycine 
• 1181215-37-1 C₃₀H₄₂BrN₃O₆ 
• 1039171-10-2 C₁₈H₃₁NO₅ 
• 26524-71-0 5-(hex-5-en-1-yl)dihydrofuran-2(3H)-one 
• 67114-38-9 5-(hex-3-en-1-yl)dihydrofuran-2(3H)-one 
• 1310810-11-7 (E)-8-phenyloct-7-ene-1,2-diol 
• 1310810-12-8 (E)-8-(o-tolyl)oct-7-ene-1,2-diol 
• 368423-70-5 Benzoic acid (3S,4S)-2-but-3-enyl-3-isopropyl-5-oxo-4-(2-oxo-oct-7-enyl)-cyclopent-1-enyl ester 
• 368423-72-7 Benzoic acid (1S,15S)-15-isopropyl-3,14-dioxo-bicyclo[10.2.1]pentadec-12-en-13-yl ester 
• 368423-71-6 Benzoic acid (Z)-(1S,15S)-15-isopropyl-3,14-dioxo-bicyclo[10.2.1]pentadeca-8,12-dien-13-yl ester 
• 556776-91-1 2,2-dimethyl-propionic acid 3-[(benzyl-dimethyl-silanyl)-methylene]-9-(2,2-dimethyl-[1,3]dioxolan-4-yl)-non-5-enyl ester 
• 300831-21-4 (S)-2-(tert-butoxycarbonylamino)non-8-enoic acid 
• 756894-33-4 ethyl (Z)-2-acetamido-2,8-nonadienoate 
• 300831-20-3 ethyl (S)-2-acetamido-8-nonenoate 

Relevant articles and documents

DERMATOLOGICAL COMPOSITIONS AND METHODS

Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds, including alcohols, diols and/or triols and their analogues.

Treatment of neurodegenerative diseases

Disclosed are methods for increasing the differentiation of mammalian neuronal cells for purposes of treating neurodegenerative diseases or nerve damage by administration of various compounds including alcohols, diols and/or triols and their analogues.

Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway

Disclosed are methods and compositions for stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway, by administration of various compounds including alcohols, diols and/or triols and their analogues.

Palladium-catalysed Synthesis of endo- and exo-Brevicomin and Related Di- and Tri-oxabicyclo Systems.

Ethyl nona-3,8-dienoate prepared from the palladium-catalysed reaction of butadiene with carbon monoxide and ethanol was found to consist of a 79:21 mixture of trans- and cis-isomers.The ester was used to prepare threo- and erythro-3,4-dihydroxynon-8-ene which were cylised by a Wacker-type catalyst (PdCl2 - CuCl2 - O2) to exo- and endo-brevicomin.Analogous cyclisations were effected on several other ene-diols derived from octa-1,6-diene, octa-1,7-diene, allyl glycidyl ether and two substituted diallyl ethers.The mechanism of the key cyclisation step is discussed.